Participants in the highest UA group (T3) exhibited higher values for coronary artery disease, chronic kidney disease, CCI ≥ 3, NYHA class III or IV, LVEDD, SCr, BUN, cystatin, lactate dehydrogenase, brain natriuretic peptide, and clinical outcomes during 6 months after discharge. This evidence concerns the gene NPPB and chronic kidney disease.